Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02699983 · ClinicalTrials.gov registry record · NA
eHealth Weight Loss Program in African American Breast Cancer Survivors
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT02699983 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 35 participants.
The verdict
NCT02699983, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
This randomized pilot clinical trial studies how well a virtual weight loss program (SparkPeople) works in helping female African American breast cancer survivors maintain a healthy weight. Many patients with breast cancer are overweight or gain weight after diagnosis. SparkPeople is a free web-based weight loss program that features educational and motivational articles and videos, self-monitoring tools, incentives, social support communities (including discussion forums, teams, challenges, and expert blogs), and options for content to be delivered to members' email. It is a comprehensive program that includes advice on diet, physical activity, and behavioral strategies (such as self-monitoring diet and exercise), and emphasizes safe weight loss and receiving medical attention regularly when needed. A web-based program such as SparkPeople may help breast cancer survivors maintain a healthy weight, which may reduce the risk of cancer returning and patient fatigue, and improve patient quality of life.
Interventions
- BEHAVIORAL Exercise Intervention
- BEHAVIORAL Behavioral Dietary Intervention
- DEVICE Activity Monitoring Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2016-01-08 |
| Est. Completion | 2018-07-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02699983
The ClinicalTrials.gov registry entry for NCT02699983 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Exercise Intervention is the first listed.
NCT02699983 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02699983 about?
NCT02699983 is a clinical study titled "eHealth Weight Loss Program in African American Breast Cancer Survivors". This randomized pilot clinical trial studies how well a virtual weight loss program (SparkPeople) works in helping female African American breast cancer survivors maintain a healthy weight. Many patients with breast cancer are overweight or gain weight after diagnosis. SparkPeople is a free web-base...
What is the current status of trial NCT02699983?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2016-01-08. Estimated completion is 2018-07-29.
What interventions are being tested in trial NCT02699983?
The interventions under investigation include: Exercise Intervention (BEHAVIORAL), Behavioral Dietary Intervention (BEHAVIORAL), Activity Monitoring Device (DEVICE).
Who is sponsoring clinical trial NCT02699983?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.